U.S. Leading Ophthalmic Diseases Markets published by Frost & Sullivan in March, 2006. This report price starts from US $ 6000.
Abstract
This Frost & Sullivan research service entitled U.S. Ophthalmic
Pharmaceuticals Markets addresses patient dynamics and forecasts, product
analysis, competitor and pipeline analysis, and market revenue forecasts for
age-related macular degeneration (AMD), chronic dry eye, ocular allergy and
ocular NSAID markets.
This analysis is available through our Pharmaceutical & Biotechnology Growth
Partnership Services program. With this program, clients receive
industry-leading market research such as this, along with technical and
econometric data and many interactive features including Analyst Inquiry Time
and Client Councils.
Table of Contents
1 EXECUTIVE SUMMARY
2 TOTAL U.S. LEADING OPHTHALMIC DISEASES MARKET
- Market Scope and Methodology
- Introduction
- Scope and Segmentation
- Research Methodology
- Market Engineering Measurements
- Glossary
- Revenue Forecast
- Market Trends
- Market Drivers
- Market Restraints
- Industry Challenges and Strategic Recommendations
- Industry Challenges
- Strategic Recommendations
- Competitive Structure
- Competitive Landscape
- Competitor Profiles
- Market Share Analysis
- Frost & Sullivan Awards for the U.S. Leading Ophthalmic Diseases Markets
- Marketing Strategy Leadership of the Year Award
- Industry Innovation Advancement of the Year Award
- Company of the Year Award
- Product Differentiation Innovation of the Year Award
3 U.S. AGE-RELATED MACULAR DEGENERATION MARKET
- Overview
- Introduction
- Market Engineering Measurements
- Product Analysis
- Pipeline Analysis
- Market Forecasts
- Prevalent and Treatment AMD Patient Forecast
- Total AMD Revenue Forecast and Assumptions
- Product Sales Forecasts
- Market Share Analysis
4 U.S. OCULAR ALLERGY MARKET - ALLERGIC CONJUNCTIVITIS
- Overview
- Introduction
- Market Engineering Measurements
- Product Analysis
- Pipeline Analysis
- Market Forecasts
- Prevalent and Treated Ocular Allergy Patient Forecast
- Total Ocular Allergy Revenue Forecast
- Market Share Analysis
5 U.S. OCULAR NSAIDS MARKET
- Overview
- Introduction
- Market Engineering Measurements
- Product Analysis
- Pipeline Analysis
- Market Forecasts
- Prevalent and Treated Ocular Inflammation Patient Forecast
- Total Ocular Inflammation Revenue Forecast
- Market Share Analysis
6 U.S. DRY EYE MARKET
- Overview
- Introduction
- Market Engineering Measurements
- Product Analysis
- Pipeline Analysis
- Market Forecasts
- Prevalent and Treated Dry Eye Patient Forecast
- Total Dry Eye Revenue Forecast
- Market Share Analysis
7 APPENDIX
- Decision Support Databases
- Total Population
- Total Healthcare Expenditure
- Pharmaceutical R&D Expenditure
- Pharmaceutical R&D Expenditure as a Percent of the Pharmaceutical Market
- Glaucoma Prevalence
